Drug Market Growth To Slow

Growth in the Belgian drug market is expected to decline in 2009, with pharmaceutical expenditure calculated to increase by only 2.41% by the end of this year, compared with the 5.16% and 5.23% rates experienced during 2007 and 2008. Drug expenditure reached EUR4.48bn (US$6.59bn) in 2008 and is expected to increase to EUR4.59bn in 2009. However, as a result of the weakening euro, pharmaceutical expenditure in US dollar terms is calculated to decline to US$6.47bn.

To read the full article, please sign in or take a free trial.